Japanese encephalitis vaccine

被引：0
作者：
不详
机构：
来源：
AUSTRALIAN PRESCRIBER | 2009年 / 32卷 / 03期
关键词：
IMMUNOGENICITY; PHASE-3; SAFETY; TRIAL; IC51;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：84 / 85
页数：2
相关论文
共 50 条
  • [21] Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
    Vadrevu, Krishna Mohan
    Potula, Venugopal
    Khalatkar, Vasant
    Mahantshetty, Niranjana S.
    Shah, Atish
    Ella, Raches
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (09) : 1478 - 1487
  • [22] A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea
    Kim, Dong Soo
    Houillon, Guy
    Jang, Gwang Cheon
    Cha, Sung-Ho
    Choi, Soo-Han
    Lee, Jin
    Kim, Hwang Min
    Kim, Ji Hong
    Kang, Jin Han
    Kim, Jong-Hyun
    Kim, Ki Hwan
    Kim, Hee Soo
    Bang, Joon
    Naimi, Zulaikha
    Bosch-Castells, Valerie
    Boaz, Mark
    Bouckenooghe, Alain
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (09) : 2656 - 2663
  • [23] Japanese Encephalitis Vaccine Acceptance and Strategies for Travelers: Insights from a Scoping Review and Practitioners in Endemic Countries
    Asawapaithulsert, Punyisa
    Ngamprasertchai, Thundon
    Kitro, Amornphat
    de la Fuente, Jose
    VACCINES, 2023, 11 (11)
  • [24] A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children
    Chokephaibulkit, Kulkanya
    Plipat, Nottasorn
    Yoksan, Sutee
    Phongsamart, Wanatpreeya
    Lappra, Keswadee
    Chearskul, Pimpanada
    Chearskul, Sanay
    Wittawatmongkol, Orasri
    Vanprapar, Nirun
    VACCINE, 2010, 28 (20) : 3563 - 3566
  • [25] Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018
    Khan, Siraj A.
    Choudhury, Parveena
    Kakati, Sanjeeb
    Doley, Rimamoni
    Barman, Manash P.
    Murhekar, Manoj, V
    Kaur, Harpreet
    VACCINE, 2021, 39 (35) : 4973 - 4978
  • [26] Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
    Dubischar-Kastner, Katrin
    Eder, Susanne
    Buerger, Vera
    Gartner-Woelfl, Gabriele
    Kaltenboeck, Astrid
    Schuller, Elisabeth
    Tauber, Erich
    Klade, Christoph
    VACCINE, 2010, 28 (32) : 5197 - 5202
  • [27] Safety of Japanese encephalitis vaccines
    Hu, Ya-Li
    Lee, Ping-Ing
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4259 - 4264
  • [28] ANTIBODY RESPONSE IN HEALTHCARE WORKERS VACCINATED WITH LIVE-ATTENUATED RECOMBINANT JAPANESE ENCEPHALITIS CHIMERIC VACCINE
    Vandepitte, Warunee Punpanich
    Chaweethamawat, Areerat
    Panakorn, Lalita
    Yoksan, Sutee
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2020, 51 (03) : 344 - 352
  • [29] IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine
    Appaiahgari, Mohan Babu
    Vrati, Sudhanshu
    EXPERT REVIEW OF VACCINES, 2010, 9 (12) : 1371 - 1384
  • [30] Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
    Chanthavanich, Pornthep
    Limkittikul, Kriengsak
    Sirivichayakul, Chukiat
    Chokejindachai, Watcharee
    Hattasingh, Weerawan
    Pengsaa, Krisana
    Surangsrirat, Surachai
    Srisuwannaporn, Termsang
    Kaewma, Benjawan
    Yoksan, Sutee
    Jun, Gao
    Zhumu, Bai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 900 - 905
12345